Grade 3b Follicular Lymphoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Grade 3b Follicular Lymphoma

hematologic malignancy

Identifier: CI-CAN-00007775
Entity page: /cancer/grade-3b-follicular-lymphoma ↗
Edges: 73

Neighbours: 33 drugs10 trials
Drawn: 43 of 43 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Grade 3b Follicular Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived33 of 33show fewer
→ investigated in trials for	Cyclophosphamidesmall molecule 11 trials (7 active) · roll-up of the cancer and its descendants	—	—	Grade 3b Follicular Lymphoma	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal antibody

Grade 3b Follicular Lymphoma studied in …STUDIED_INderived10 of 40show all (up to 200)
→ studied in	NCT05359211Phase 1 · completed NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma · condition mapped CURATED_BROADER · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05025800Phase 1/Phase 2 · active not recruiting ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06830031Phase 1 · recruiting Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma · condition mapped ALIAS · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07098364Phase 1/Phase 2 · suspended ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07814001Phase 2 · not yet recruiting Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy · condition mapped CURATED_BROADER · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06784726Phase 2 · recruiting Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T · condition mapped CURATED_BROADER · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06536049Phase 1/Phase 2 · recruiting Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03150329Phase 1 · active not recruiting Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. · condition mapped ONTOLOGY_EXACT · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07735533Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07750886recruiting Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) · condition mapped ALIAS · 40 trials mapped (28 active)	—	—	Grade 3b Follicular Lymphoma	1	Observed	clinicaltrials	graph →